Home Autism Common pain reliever used in pregnancy not linked to autism risk

Common pain reliever used in pregnancy not linked to autism risk

Credit: Unsplash+

Acetaminophen, also known as paracetamol or by brand names such as Tylenol, is one of the most widely used medicines in the world.

It is commonly taken to reduce pain and fever and is often recommended during pregnancy because it has long been considered one of the safer options compared to other pain medications.

However, in recent years, concerns have grown about whether using this drug during pregnancy could affect a child’s brain development, especially the risk of autism.

Autism is a condition that affects how a person communicates, interacts with others, and experiences the world. Because it begins early in life, researchers have spent many years trying to understand what factors during pregnancy might influence its development. This has led to many studies looking at medications, environment, and genetics.

Some earlier research suggested there might be a small link between acetaminophen use in pregnancy and autism.

These findings received a lot of attention from the media and the public, which caused worry among many parents and pregnant women. As a result, health authorities, including the U.S. Food and Drug Administration, advised doctors to be cautious when recommending the drug for minor symptoms.

However, the scientific evidence has not been consistent. Some studies found a possible link, while others did not. One important issue is that many factors can influence a child’s development, including genetics, family environment, and other health conditions. This makes it difficult to know whether the drug itself is responsible.

To better understand the situation, researchers carried out a very large study in Denmark. The results were published in the journal JAMA Pediatrics. The study included more than 1.5 million children born between 1997 and 2022. This makes it one of the largest studies ever conducted on this topic.

The researchers used national health records to track both medication use during pregnancy and later diagnoses of autism in children.

They also used a method called sibling comparison, where they compared children from the same family. This method is important because siblings share many genetic and environmental factors, helping to reduce hidden bias in the results.

The findings were clear. There was no increase in autism risk among children whose mothers took acetaminophen during pregnancy. This was true both in the general population and in sibling comparisons. The results also did not change based on how much medication was taken or when during pregnancy it was used.

This suggests that earlier concerns may have been influenced by other factors rather than the medication itself. For example, women who take acetaminophen during pregnancy may do so because of underlying health conditions, which could also be linked to developmental outcomes.

While this study provides strong evidence, it is important to understand its limits. Even large studies cannot prove absolute safety, and researchers always continue to study long-term effects. However, this study is very robust because of its size, design, and use of detailed national data.

In conclusion, this research offers reassurance to pregnant women and healthcare providers. It suggests that acetaminophen, when used appropriately, does not increase the risk of autism in children. This can help guide informed decisions and reduce unnecessary worry.

If you care about autism, please read studies about a new cause of autism, and cats may help decrease anxiety for kids with autism.

For more information about health, please see recent studies about vitamin D that may hold the clue to more autism, and results showing strange eating habits may signal autism.

Source: JAMA Pediatrics (Denmark study).